| |
 |
Editorial [Hot Topic: Rising of Phosphatases as Targets of Cancer Treatment (Guest Editor: Petr Heneberg)]
 |
| |
|
pp.1-3 (3) Author: Petr Heneberg |
| |
|
|
| |
|
Tumor Promoters - Microcystin-LR, Nodularin and TNF-α and Human Cancer Development
|
| |
|
pp.4-18 (15) Authors: Hirota Fujiki, Masami Suganuma |
| |
|
|
| |
|
Can We Effectively Degrade Microcystins? - Implications on Human Health
|
| |
|
pp.19-37 (19) Authors: Armah A. de la Cruz, Maria G. Antoniou, Anastasia Hiskia, Miguel Pelaez, Weihua Song, Kevin E. O'Shea, Xuexiang He, Dionysios D. Dionysiou |
| |
|
|
| |
|
Protein Phosphatase 2A as a Potential Target for Anticancer Therapy
|
| |
|
pp.38-46 (9) Authors: Peter Kalev, Anna A. Sablina |
| |
|
|
| |
|
In-Gel Protein Phosphatase Assays and Other Useful Methods for the Detection of Protein Phosphatase Activities
|
| |
|
pp.47-53 (7) Authors: Atsuhiko Ishida, Isamu Kameshita |
| |
|
|
| |
|
Recent Advances in Protein Tyrosine Phosphatase Detection Using Chemical Probes
|
| |
|
pp.54-63 (10) Authors: Kyeong Lee, Hyo Jin Kang, Yan Xia, Sang J. Chung |
| |
|
|
| |
|
Regulatory Cascades of Protein Phosphatases: Implications for Cancer Treatment
|
| |
|
pp.64-77 (14) Authors: Noor Jailkhani, Virendra K. Chaudhri, Kanury V.S. Rao |
| |
|
|
| |
|
PTPN13/PTPL1: An Important Regulator of Tumor Aggressiveness
|
| |
|
pp.78-88 (11) Authors: Gilles Freiss, Dany Chalbos |
| |
|
|
| |
|
SHP-1 in Cell-Cycle Regulation
|
| |
|
pp.89-98 (10) Authors: Pilar Lopez-Ruiz, Javier Rodriguez-Ubreva, Ariel Ernesto Cariaga, Maria Alicia Cortes, Begona Colas |
| |
|
|
| |
|
PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
|
| |
|
pp.99-108 (10) Authors: Katarzyna Guzinska-Ustymowicz, Anna Pryczynicz |
| |
|
|
| |
|
Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment
|
| |
|
pp.109-132 (24) Authors: Caroline Nunes-Xavier, Carlos Roma-Mateo, Pablo Rios, Celine Tarrega, Rocio Cejudo-Marin, Lydia Tabernero, Rafael Pulido |
| |
|
|
| |
|
Tumor-Derived Extracellular Fragments of Receptor Protein Tyrosine Phosphatases (RPTPs) as Cancer Molecular Diagnostic Tools
|
| |
|
pp.133-140 (8) Authors: Sonya E.L. Craig, Susann M. Brady-Kalnay |
| |
|
|
| |
|
High-Throughput Methods in Identification of Protein Tyrosine Phosphatase Inhibitors and Activators
|
| |
|
pp.141-150 (10) Authors: Elina Mattila, Johanna Ivaska |
| |
|
|
| |
|
Molecular Field Analysis (MFA) and Other QSAR Techniques in Development of Phosphatase Inhibitors
|
| |
|
pp.151-163 (13) Author: Pramod C. Nair |
| |
|
|
| |
|
Metal-Based Inhibitors of Protein Tyrosine Phosphatases
|
| |
|
pp.164-171 (8) Authors: Liping Lu, Miaoli Zhu |
| |
|
|
